Tci Wealth Advisors, Inc. Bellus Health Inc. Transaction History

Tci Wealth Advisors, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 08, 2022	SELL	$8.95 - $12.0 $894 - $1,200	-100 Reduced 50.0%	100 $1,000
Q3 2021 Oct 29, 2021	SELL	$2.7 - $6.64 $270 - $664	-100 Reduced 33.33%	200 $1,000
Q4 2020 Jan 21, 2021	SELL	$2.27 - $3.3 $227 - $330	-100 Reduced 25.0%	300 $1,000
Q3 2020 Oct 20, 2020	BUY	$2.14 - $12.02 $856 - $4,808	400 New	400 $1,000

128K

Ticker BLU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,793,000
Description
BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of RCC and chronic pruritus. Th...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.